+
Site Tour
TRICLIP™
TRICUSPID
VALVE REPAIR
TRANSCATHETER
EDGE-TO-EDGE REPAIR (TEER)

 

TriClip™ Transcatheter Edge-to-Edge Repair (TEER) offers a minimally invasive
treatment option for patients with symptomatic, severe tricuspid regurgitation (TR)
who are at high risk for surgery.1

NOTHING EVOKES SAFETY LIKE TRICLIP.

99.6%

FREEDOM FROM
CARDIOVASCULAR MORTALITY
AT 30 DAYS23

98.9%

FREEDOM FROM
MAJOR AES
AT 30 DAYS23

Explore Now

THE STANDARD OF CARING FOR TR

The TriClip Transcatheter Edge-to-Edge Repair (TEER) system is the only TEER device intentionally designed for the tricuspid valve. With stable navigation and precise delivery,2-5 TriClip TEER is the only tricuspid device proven to reduce risk of heart failure hospitalization and improve quality of life, relative to optimal medical therapy.6 In both randomized and real-world studies, TriClip TEER has proven:

Exceptional safety profile9,10

Maximized effectiveness in tricuspid regurgitation (TR) reduction6,7

Life Changing Improvements to heart failure hospitalization risk and quality of life6,7,9,10

LEARN MORE:

EuroPCR Symposium 2025 EuroPCR 2025 TRILUMINATE PODIUM DECK bRIGHT PODIUM DECK

PCR London Valves 2024  CLINICAL DATA

Connext
TV

CONNECT TO THE LATEST
IN STRUCTURAL HEART
THERAPY

Find out more

TV

TriClip™ patient story: Lindel

A patient with severe symptoms of a leaky tricuspid valve treated with Abbott’s minimally-invasive tricuspid valve repair technology

Unbox MitraClip and TriClip G5 systems

Join Gagan Singh and Roi Estevez, as they unbox MitraClip and TriClip G5

Discover MitraClip and TriClip G5 systems

MitraClip & TriClip G5: Control meets Efficiency

ESC Tutorial 2024 E.Donal | Hands-on

ESC Tutorials 2024
Procedural hands-on| All you need to know to treat Tricuspid Regurgitation with Transcatheter Edge-to-Edge Repair

ESC Tutorial 2024 N.Brugger

ESC Tutorials 2024
Procedural hands-on| All you need to know to treat Mitral Regurgitation with Transcatheter Edge-to-Edge Repair

ESC Tutorial 2024 E.Donal

ESC Tutorials 2024
Live echocardiography | Monitor and follow up your patients post Tricuspid Transcatheter Edge-to-Edge Repair procedure

ESC Tutorial 2024 A.Coisne, M.Glaso

ESC Tutorials 2024
Live echocardiography | Diagnose, Screen and Refer your patients to Transcatheter Edge-to-Edge Repair

ESC Tutorial 2024 R.S. von Bardeleben

ESC Tutorials 2024
Live echocardiography | Monitor and follow up your patients post Mitral Transcatheter Edge-to-Edge Repair procedure

HFA Tutorial 2025 E. Donal | Case based

HFA Tutorials 2025
Case based | How to manage a Secondary AV valve disease, with a focus on Tricuspid

HFA Tutorials 2025 E. Donal

HFA Tutorials 2025
Simulation & Hands-on | How to treat an HF patient with the TEER therapy

References
  1. TriClip G5 System IFU
  2. Abbott. Data on file. PS2203200
  3. Abbott. Data on file. PS2203401
  4. Abbott. Data on file. PS2203500
  5. Abbott. Data on file. PS2203501
  6. Kar S, Makkar RR, Whisenant BK, et al. Two-year outcomes of transcatheter edge-to-edge repair for severe tricuspid regurgitation: The TRILUMINATE Pivotal Randomized Trial. Circulation. March 30, 2025. doi:10.1161/CIRCULATIONAHA.125.074536
  7. Estevez-Loureiro R. Real-world Outcomes for Tricuspid Edge-to-Edge Repair: Initial 2-year Outcomes from the bRIGHT Trial. Presented at PCR London Valves on November 19-21, 2023; London, UK.
  8. Adams D, Sorajja P, et al. TRILUMINATE Pivotal: Outcomes of All Randomized and Single-arm Subjects with Transcatheter Tricuspid Valve Edge-to-Edge Repair for Tricuspid Regurgitation. Presented at TCT on October 24, 2023; San Francisco, CA; USA.
  9. Tang GHL, Hahn RT, Whisenant BK, et al. Tricuspid transcatheter edge-to-edge repair for severe tricuspid regurgitation: 1-year outcomes from the TRILUMINATE randomized cohort. J Am Coll Cardiol. Published online 2025;85(3):235-246. doi:10.1016/j.jacc.2024.10.08
  10. Lurz P, Rommel KP, Schmitz T, et al. Real-world 1-year results of tricuspid edge-to-edge repair from the bRIGHT study. J Am Coll Cardiol. 2024;84(7):607-616. doi:10.1016/j.jacc.2024.05.006
  11. Sorajja P, Whisenant B, Hamid N, et al. Transcatheter repair for patients with tricuspid regurgitation. NEJM. March 4, 2023. doi: 10.1056/NEJMoa2300525.
  12. www.mayoclinic.org. Accessed February 2024
  13. Benfari G, Antoine C, Mille WL, et al. Excess mortality associated with functional tricuspid regurgitation complicating heart failure with reduced ejection fraction. Circulation. 2019;140(3):196-206.
  14. Asmarats L, Puri R, Latib A, et al. Transcatheter tricuspid valve interventions: landscape, challenges, and future directions. J Am Coll Cardiol. 2018;71(25):2935-2956.
  15. Enriquez-Sarano M, Messika-Zeitoun D, Topilsky Y, et al. Tricuspid regurgitation is a public health crisis [published online ahead of print November 9, 2019]. Prog Cardiovasc Dis. 2019;62(6):447-451. Doi:10.1016/j.pcad.2019.10.009.
  16. Wong WK, Chen SW, Chou AH, et al. Late outcomes of valve repair versus replacement in isolated and concomitant tricuspid valve surgery: a nationwide cohort study. J Am Heart Assoc. 2020;9(8):e015637. doi:10.1161/JAHA.119.015637.
  17. Zack CJ, Fender EA, Chandrashekar P, et al, National trends and outcomes in isolated tricuspid valve surgery. J Am Coll Cardiol. 2017;70(24):2953–2960. doi:10.1016/j.jacc.2017.10.039.
  18. Chen Q, Bowdish ME, Malas J, et al. Isolated tricuspid operations: The Society of Thoracic Surgeons Adult cardiac surgery database analysis. Ann Thorac Surg. 2023;115(5):1162–1170. doi:10.1016/j.athoracsur.2022.12.041.Data on File at Abbott.
  19. Data on File at Abbott.
  20. Abbott. Data on file. RPT2139672
  21. Test(s) performed by and data on file at Abbott. (RPT2133700, RPT2122822-R, RPT2124838-R)
  22. Lurz P, et al. Real-world Outcomes for Tricuspid Edge-to-Edge Repair: Initial 30-Day Results from the TriClip™ bRIGHT Study. Data presented at Euro PCR 2022.
  23. Tang, G, Hahn, R, Whisenant, B. et al. Tricuspid Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: 1-Year Outcomes From the TRILUMINATE Randomized Cohort. JACC. 2025 Jan, 85 (3) 235-246. doi.org/10.1016/jjacc.2024.10.086

© Abbott 2025. All rights reserved. 9-EH-5-14379-01 09-2025 REV H

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline